PSG In Lab denied due to quantity / dose limits by Aetna?
Quantity-limit denials usually flip when the appeal documents the clinically appropriate dose for the patient's weight, kidney function, or escalation schedule, citing the FDA label or specialty-society guideline.
US health-plan appeal rights
Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules
Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.
What Aetna typically requires
Aetna's specific coverage criteria for psg in lab are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.
The Aetna angle on PSG In Lab
## Why Aetna Applies Quantity Limits to In-Lab PSG
Aetna's quantity-limit denials for in-lab polysomnography typically arise when a patient needs a repeat study — for example, a titration night, a split-night study follow-up, or a repeat diagnostic study after a change in clinical status — and the plan has reached its covered-study limit for a defined period. The insurer's position is that additional studies exceed what is ordinarily necessary. These denials are routinely overturned when clinical documentation shows that the additional study was medically necessary for a specific, distinct clinical reason.
## Your Federal Appeal Rights
- Internal appeal: Under ACA §2719 and ERISA §503, Aetna must conduct a full-and-fair clinical review and explain the specific quantity-limit provision it applied. You have the right to see that policy language.
- External review: After exhausting the internal appeal, independent external review is available, typically within approximately four months of the final denial.
- Expedited track: Available if your situation is clinically urgent — for example, if untreated sleep-disordered breathing poses an acute safety risk.
## Documentation to Gather
1. Prior study records — dates and clinical findings of all previous studies, including what each study was ordered for and what was found. 2. Clinical basis for additional study — your physician should document why the additional study is not duplicative. Common valid reasons include a change in clinical status, inadequate therapeutic response, significant weight change, new or worsening comorbidities, or a technically failed prior study. 3. Prescriber medical-necessity letter — specifically addressing why the additional study is clinically distinct from prior studies and why it is necessary at this time. 4. Applicable AASM guideline reference — your physician should cite the relevant American Academy of Sleep Medicine guidance that supports repeat or additional PSG in your specific clinical scenario.
## Criteria-Mapping Structure
Obtain the exact quantity-limit provision from Aetna's clinical policy and map each element:
| Aetna Quantity-Limit Criterion | How Your Situation Qualifies for an Exception | |---|---| | [Paste the limit and exception language] | [Quote chart notes, dates, and clinical rationale from your physician] |
## Key Argument
The strongest quantity-limit appeals demonstrate that the additional study addresses a clinically new or changed question — not simply repeating a prior test without new indication. Your physician's letter should make this distinction explicit and tie it to a specific guideline or clinical standard.
## Next Step
Request Aetna's clinical policy for sleep testing quantity limits in writing before submitting your appeal. Confirm the exact limit applied and the exception criteria, then build your appeal letter to address each exception criterion with specific chart evidence.
Next steps
- Find the date on the denial letter — your appeal window starts there.
- Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
- Request the insurer's claim file in writing — they must provide it.
- Submit your appeal in writing with new clinical evidence and a physician statement.
Get the letter drafted
DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.
Start my appeal — $30 with code SEO25 →